Novus Therapeutics, Inc.
19900 MacArthur Blvd., Suite 550
Irvine, California 92612
(949) 238-8090
July 30, 2018
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attn: Irene Paik
| Re: | Novus Therapeutics, Inc. |
Registration Statement on Form S-3
Filed July 23, 2018
File No. 333-226286
Ladies and Gentlemen:
Pursuant to Rules 460 and 461 promulgated under the Securities Act of 1933, as amended, Novus Therapeutics, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective time of the above referenced Registration Statement on Form S-3 filed by the Company (the “Registration Statement”) be accelerated to 4:00 p.m., Eastern Daylight Time, on, July 31, 2018 or as soon thereafter as practicable.
[Signature page follows]
| Very truly yours, |
| Novus Therapeutics, Inc. |
| /s/ Gregory J. Flesher |
| Gregory J. Flesher |
| Chief Executive Officer |
| cc: | Ryan A. Murr, Gibson, Dunn & Crutcher LLP |